Juvena Therapeutics raised $79.5 million to advance protein-based therapeutics that restore cellular function and promote tissue repair for chronic and rare diseases.
Juvena Therapeutics raised $79.5 million to advance protein-based therapeutics that restore cellular function and promote tissue repair for chronic and rare diseases.